HemoShear Adds Industry Veterans Mehmood Khan and Fred Brown to Board of Managers

   HemoShear Adds Industry Veterans Mehmood Khan and Fred Brown to Board of
                                   Managers

PR Newswire

CHARLOTTESVILLE, Va., Nov. 13, 2012

CHARLOTTESVILLE, Va., Nov. 13, 2012 /PRNewswire/ --HemoShear LLC, a
biotechnology research company and leading developer of human-relevant systems
for discovery and assessment of new drug compounds, today announced that two
successful pharmaceutical industry veterans have joined its Board of
Managers. Mehmood Khan, M.D., Executive Vice President and Chief Scientific
Officer, Global Research and Development for PepsiCo, Inc., and Frederick W.
K. Brown, M.B.A., Chief Innovation and New Venture Officer at Ascension Health
in Michigan, have agreed to serve on HemoShear's Board.

(Logo: http://photos.prnewswire.com/prnh/20120416/PH86899LOGO)

"We are thrilled to have Mehmood and Fred join our board," said Jim Powers,
HemoShear's CEO. "The building of a great company requires the leadership of a
distinguished Board of Managers with records of success in building and
leading commercial enterprises within the pharmaceutical industry. I am proud
that HemoShear was able to gain the support of such prominent individuals.As
we move forward with our plans to transform the productivity of pharmaceutical
R&D, the experience and perspectives of Dr. Khan and Mr. Brown will be
extremely valuable."

As PepsiCo's EVP and Chief Scientific Officer, Dr. Khan leads PepsiCo's
research and development efforts, including nutrition, medicine, research,
science, marketing/branding, and product innovation. He also directs PepsiCo's
enterprise planning, portfolio development, and implementation of new
technologies to grow PepsiCo's nutrition-focused brands. Prior to joining
PepsiCo, Dr. Khan was President, Takeda Global Research & Development Center,
overseeing Takeda's worldwide R&D efforts. He joined Takeda after serving as
Director of the Diabetes, Endocrine and Nutrition Clinical Trials Unit and as
Senior Associate Consultant in the Division of Endocrinology at the Mayo
Clinic.

Prior to joining Ascension Health, Mr. Brown was President of the Navigator
Health Services division of Diplomat Specialty Pharmacy, the largest
independent specialty pharmacy in the world, which was awarded the INC 500
prize as the fastest growing healthcare company in the U.S. in 2009 and 2010.
Before that he served as Global Head of Partnering and Product Lifecycle
Management at Hoffmann-La Roche. As a top healthcare consultant, Mr. Brown
served as Executive Vice President, Global Services EMEA, of the Life
Sciences/Healthcare Division of IBM, and he co-founded Anderson Consulting's
(now Accenture's) Pharmaceutical and Medicinal Products Practice in the US and
Europe.

About HemoShear LLC
By applying physiologically accurate hemodynamics and biological transport to
primary cell cultures, HemoShearcreates human-relevant systems that
accurately replicate the biology of organ systems and diseases throughout drug
discovery and development.Working in strategic partnerships with
pharmaceutical, biotechnology and medical device companies, HemoShear
generates meaningful data to increase confidence in decision-making, reduce
risk of costly failures and identify efficacious therapies.HemoShear's
science leads to new medicines and improves human health.

SOURCE HemoShear LLC

Website: http://www.hemoshear.com
Contact: Rusty Speidel, +1-434-284-3403, rspeidel@jaggerscommunications.com
 
Press spacebar to pause and continue. Press esc to stop.